Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Accentis NV | ACCB | Apr 17, 2025 | 0.03 | 0.00 |
Ackermans & van Haaren NV | ACKB | Apr 17, 2025 | 201.80 | -0.39 |
Aedifica SA | AED | Apr 17, 2025 | 67.55 | +1.05 |
Ageas | AGS | Apr 17, 2025 | 52.80 | -0.94 |
Agfa-Gevaert NV | AGFB | Apr 17, 2025 | 0.88 | +1.73 |
AHOLD DEL | AD | Apr 17, 2025 | 34.55 | +0.55 |
APERAM | APAM | Apr 17, 2025 | 26.00 | +0.39 |
Argen X SE | ARGX | Apr 17, 2025 | 524.20 | +0.15 |
Ascencio Sca | ASCE | Apr 17, 2025 | 45.25 | +1.00 |
Atenor | ATEB | Apr 17, 2025 | 2.84 | -2.07 |
AVANTIUM | AVTX | Apr 17, 2025 | 0.78 | +0.13 |
Azelis Group NV | AZE | Apr 17, 2025 | 15.08 | -2.01 |
Banco Bilbao Vizcaya Argentaria SA | BBV | Apr 17, 2025 | 7.80 | 0.00 |
Banco Santander SA | SANTA | Apr 17, 2025 | 3.58 | 0.00 |
Banimmo SA | BANI | Apr 17, 2025 | 2.93 | 0.00 |
Banque Nationale de Belgique | BNB | Apr 17, 2025 | 318.00 | -0.63 |
Barco NV | BAR | Apr 17, 2025 | 11.32 | +1.25 |
Basilix | BAS | Apr 17, 2025 | 27.80 | 0.00 |
Beaulieu Av Certificates | BEAB | Apr 17, 2025 | 1.19 | 0.00 |
Befimmo SA | BEFB | Apr 17, 2025 | 46.10 | 0.00 |
Bel20 | BEL20 | Apr 17, 2025 | 4 197.65 | -0.08 |
Belreca - Belgian Resources and Capital Company | BELR | Apr 17, 2025 | 7.50 | 0.00 |
Beluga NV | BELU | Apr 17, 2025 | 0.32 | 0.00 |
Belysse Group N.V. | BELYS | Apr 17, 2025 | 0.79 | +2.60 |
Biocartis Group NV | BCART | Apr 17, 2025 | 0.29 | 0.00 |
Biosenic | BIOS | Apr 17, 2025 | 0.00 | 0.00 |
Biotalys | BTLS | Apr 17, 2025 | 3.12 | 0.00 |
Boeing | BOEI | Apr 17, 2025 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Apr 17, 2025 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 17, 2025 | 1.39 | +1.90 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.